Similar articles

• [Platelet anti-aggregant drugs and ischemic cardiopathy: evaluation of the effect on platelet aggregation and on antithrombin III].

  Avellone G, Mandalà V, Novo S, Pinto A, Riolo FP, Davì G, Raneli G. Avellone G, et al. Boll Soc Ital Cardiol. 1981;26(8):697-712. Boll Soc Ital Cardiol. 1981. PMID: 6289854 Review. Italian. No abstract available.
• [Prophylactic value of platelet anti-aggregants in coronary disease].

  Verstraete M. Verstraete M. Clin Ter. 1979 Oct 31;91(2):117-27. Clin Ter. 1979. PMID: 396098 Review. Italian. No abstract available.
• [Critical evaluation of the usefulness of drugs inhibiting platelet function in the prevention of postoperative deep venous thrombosis and in ischemic cardiopathy].

  Verstraete M. Verstraete M. Recenti Prog Med. 1980 Apr;68(4):361-81. Recenti Prog Med. 1980. PMID: 6992244 Review. Italian. No abstract available.
• [Anti-aggregation therapy of patients with ischemic heart disease].

  Liusov VA, Savenkov MP. Liusov VA, et al. Ter Arkh. 1988;60(8):55-9. Ter Arkh. 1988. PMID: 3227479 Russian. No abstract available.
• [Aggregative function of thrombocytes and the status of the anticoagulation system of the blood in patients with ischemic heart disease during treatment with nitroderm].

  Zadionchenko VS, Kamenker ES, Smirnov VK, Akhmedova FD, Vasil'ev KA. Zadionchenko VS, et al. Klin Med (Mosk). 1989 Mar;67(3):72-3. Klin Med (Mosk). 1989. PMID: 2501553 Russian. No abstract available.